SNAP Brands Ventures Ltd. and Sonde Health Agree to Develop Vocal Biomarker Platform for SNAP Brands Customers

Sonde Health is contributing its patented vocal biomarker technology and talented team in a three-phase development program. SNAP intends to create its own unique IP from the health analysis platform. The platform utilized by SNAP is for general health and specifically targeted health conditions that correlate with the ÜrSTAXTM high-quality line of health supplements and enables a tailored package of supplements based on the unique profile of the customer identified as ÜrBioCODETM.